Spotlight on Pimavanserin Tartrate and Its Therapeutic Potential in the Treatment of Major Depressive Disorder: The Evidence to Date

Major depressive disorder (MDD) is widely prevalent and one of the leading causes of disability. Treatment outcomes remain suboptimal with 1 in 3 patients with MDD responding inadequately to commonly used antidepressants. Pimavanserin, an atypical antipsychotic that modulates serotonergic neurotrans...

Descripción completa

Detalles Bibliográficos
Autores principales: Soogrim, Vicki, Ruberto, Valerie L, Murrough, James, Jha, Manish Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812044/
https://www.ncbi.nlm.nih.gov/pubmed/33469267
http://dx.doi.org/10.2147/DDDT.S240862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812044/
https://www.ncbi.nlm.nih.gov/pubmed/33469267
http://dx.doi.org/10.2147/DDDT.S240862

Ejemplares similares